UCBJY:OTCMKTS
UCB Unsponsored Belgium ADR
114,46Â US$
arrow_downward
-0,87%(-1,01) 1D
16 tet, 4:00:00 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për UCBJY...
Hap
114,95Â US$
I lartë
115,28Â US$
I ulët
114,23Â US$
Kapitalizimi i tregut
39,39Â mld
Vëllimi mesatar
53,31 mijë
Vëllimi
70,57 mijë
Maksimumi 52-javor
168,76Â US$
Minimumi 52-javor
110,55Â US$
Beta
0,57
Aksionet në qarkullim
389,01Â mln
Numri i punonjësve
9 mijë
Hap
114,95Â US$
I lartë
115,28Â US$
I ulët
114,23Â US$
Kapitalizimi i tregut
39,39Â mld
Vëllimi mesatar
53,31 mijë
Vëllimi
70,57 mijë
Maksimumi 52-javor
168,76Â US$
Minimumi 52-javor
110,55Â US$
Beta
0,57
Aksionet në qarkullim
389,01Â mln
Numri i punonjësve
9 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
ad-hoc-news.de
·
1 ditë më parë
UCB launches Wear It Out: what it means for UCB stock
Profili
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
Rreth UCB Unsponsored Belgium ADR
Drejtori ekzekutivJean-Christophe Tellier
Punonjësit9 mijë
Themeluar më18 jan 1928
Selia-
Sektori-
Uebsajtiucb.com